Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. (HALO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
halo · stock forecast · 27 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 27 Wall Street analysts in the past 3 months
Buy
27 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$95.00
Consensus
$88.25
+23.4% upside
Low
$75.00
Median: $91.5 · Last Close: $71.53
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$88.25
23.4% upside
High Target
$95
32.8%
Low Target
$75
4.9%
Current Price
$71.53
as of today
Based on analyst price targets, the HALO stock price prediction for the next 12 months ranges from $75 to $95. The consensus HALO price forecast of $88.25 implies 23.4% upside from the current price of $71.53.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $72.13 | ↑ 0.84% |
1-day model range: $71.84–$72.43. Peak: $72.43 (+0.84%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $108 | +50.5% |
| 2028 | $140 | +96.2% |
| 2029 | $166 | +131.9% |
| 2030 | $184 | +157.2% |
| 2031 | — | +174.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HALO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-04-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-19 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2026-02-19 | Benchmark | Maintains | Buy→Buy |
| 2026-01-08 | TD Cowen | Maintains | Buy→Buy |
| 2025-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-18 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-11-04 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-27 | JP Morgan | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Halozyme Therapeutics, Inc. (HALO) stock. Of the recent 178 rating actions, 8 were upgrades and 13 were downgrades. 27 analysts currently cover HALO.
Analyst Recommendation Trends
HALO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.8B
↓ 18.6% YoY
Revenue Next Year
$2.0B
↑ 12.8% YoY
EPS This Year
$8.11
EPS Next Year
$9.93
↑ 22.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast HALO EPS of $8.11 for the current fiscal year, based on estimates from 4 analysts. The HALO revenue forecast is $1.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HALO stock forecast is supported by two independent data sources: analyst consensus ratings from 27 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HALO price target is $88.25 (+23.4% upside), with an analyst consensus of Buy.
The HALO short-term stock prediction for tomorrow is $72.13 (+0.84%). The HALO stock price prediction for 2027 estimates an average of $108. The HALO stock prediction for 2030 projects a range of $176–$192.
Halozyme Therapeutics, Inc. trades on NASDAQ under the ticker HALO. The HALO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 63% of covering analysts.
Frequently asked questions
HALO forecast · 8 questionsAccording to 27 Wall Street analysts, the average 12-month HALO price target is $88.25, with a high forecast of $95.00 and a low of $75.00. The median price target is shown in the chart above when available. This implies +23.4% potential upside from the current price of $71.53.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.